BHWM
ABBV icon

Bay Harbor Wealth Management’s AbbVie ABBV Stock Holding History

Bay Harbor Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$311K Buy
1,237
+546
+79% +$117K 0.07% 55
2026
Q1 		$150K Buy
691
+6
+0.9% +$1.33K 0.04% 59
2025
Q4 		$157K Buy
685
+14
+2% +$3.19K 0.04% 61
2025
Q3 		$155K Buy
671
+17
+3% +$3.46K 0.04% 59
2025
Q2 		$121K Buy
654
+45
+7% +$8.36K 0.04% 70
2025
Q1 		$128K Buy
609
+71
+13% +$13.8K 0.04% 58
2024
Q4 		$95.6K Buy
538
+37
+7% +$6.8K 0.03% 74
2024
Q3 		$98.9K Sell
501
-12
-2% -$2.24K 0.03% 64
2024
Q2 		$88K Buy
513
+16
+3% +$2.65K 0.03% 70
2024
Q1 		$90.5K Sell
497
-4
-0.8% -$689 0.03% 72
2023
Q4 		$77.6K Buy
501
+2
+0.4% +$292 0.03% 77
2023
Q3 		$74.4K Buy
499
+6
+1% +$881 0.03% 68
2023
Q2 		$66.4K Sell
493
-38
-7% -$5.57K 0.03% 79
2023
Q1 		$84.6K Sell
531
-34
-6% -$5.2K 0.04% 55
2022
Q4 		$91K Sell
565
-10
-2% -$1.53K 0.04% 49
2022
Q3 		$77K Sell
575
-20
-3% -$2.87K 0.04% 57
2022
Q2 		$91K Hold
595
– – 0.04% 52
2022
Q1 		$96K Sell
595
-144
-19% -$20.9K 0.04% 52
2021
Q4 		$105K Sell
739
-121
-14% -$14.3K 0.04% 52
2021
Q3 		$93K Sell
860
-132
-13% -$15.1K 0.04% 64
2021
Q2 		$112K Sell
992
-441
-31% -$49.7K 0.05% 69
2021
Q1 		$155K Sell
1,433
-411
-22% -$44K 0.07% 60
2020
Q4 		$198K Sell
1,844
-1,017
-36% -$97.7K 0.09% 73
2020
Q3 		$251K Sell
2,861
-1,319
-32% -$124K 0.13% 68
2020
Q2 		$410K Sell
4,180
-923
-18% -$81.3K 0.22% 59
2020
Q1 		$389K Sell
5,103
-229
-4% -$19.5K 0.24% 52
2019
Q4 		$472K Sell
5,332
-13
-0.2% -$1.08K 0.25% 52
2019
Q3 		$397K Buy
5,345
+558
+12% +$38.3K 0.24% 56
2019
Q2 		$348K Sell
4,787
-105
-2% -$8.25K 0.22% 68
2019
Q1 		$394K Buy
4,892
+743
+18% +$60.8K 0.27% 62
2018
Q4 		$382K Buy
+4,149
New +$365K 0.3% 57

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Bay Harbor Wealth Management's ABBV Position: Q2 2026 in Review

Bay Harbor Wealth Management increased its AbbVie (ABBV) stake by 79% in Q2 2026, buying an estimated $117K and bringing the position to 1,237 shares worth $311K. The position accounts for 0.07% of the portfolio, ranked #55.

Bay Harbor Wealth Management first reported a position in ABBV in Q4 2018 and has held it in 31 quarters since. The position peaked at $472K in Q4 2019. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Bay Harbor Wealth Management held 1,237 shares of AbbVie worth $311K as of Q2 2026.
  • Bay Harbor Wealth Management bought 546 AbbVie shares in Q2 2026, an estimated $117K.
  • AbbVie made up 0.07% of Bay Harbor Wealth Management's portfolio in Q2 2026, its #55 holding.
  • Bay Harbor Wealth Management first reported a position in AbbVie in Q4 2018 and has held it in 31 quarters since.
  • Bay Harbor Wealth Management's AbbVie position peaked at $472K in Q4 2019.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Bay Harbor Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.